We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+4.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.04B
AUM Growth
+$73M
(+1.2%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-2.38%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
1,047
New
173
Increased
233
Reduced
390
Closed
225
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$50M |
| 2 |
Merck
MRK
|
+$46.7M |
| 3 |
Cognizant
CTSH
|
+$37.2M |
| 4 |
Las Vegas Sands
LVS
|
+$25.6M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$51.6M |
| 2 |
Comcast
CMCSA
|
+$48.7M |
| 3 |
Intel
INTC
|
+$38.4M |
| 4 |
Amazon
AMZN
|
+$38.4M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
+$36.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.81% |
| 2 | Industrials | 13.63% |
| 3 | Financials | 13.56% |
| 4 | Healthcare | 12.66% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYA
676
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $384K | 0.01% |
16,900
-228,530
| -93% | -$4.79M |
|
|
IVAC
677
DELISTED
Intevac Inc
IVAC
| $383K | 0.01% |
47,796
+4,496
| +10% | +$36.3K |
|
|
PGNX
678
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $381K | 0.01% |
88,400
-50,600
| -36% | -$193K |
|
679
Middleby
MIDD
$6.05B
| $379K | 0.01% |
4,578
-810
| -15% | -$66.7K |
|
|
N
680
DELISTED
Netsuite Inc
N
| $379K | 0.01% |
4,362
-6,310
| -59% | -$509K |
|
|
CYBX
681
DELISTED
CYBERONICS INC
CYBX
| $379K | 0.01% |
6,070
-15,060
| -71% | -$917K |
|
|
NGHC
682
DELISTED
National General Holdings Corp
NGHC
| $378K | 0.01% |
+21,700
| New | +$331K |
|
|
QLTY
683
DELISTED
QUALITY DISTR INC FLA
QLTY
| $374K | 0.01% |
+25,200
| New | +$347K |
|
|
SUMR
684
DELISTED
Summer Infant, Inc.
SUMR
| $370K | 0.01% |
14,256
+7,389
| +108% | +$167K |
|
685
TriCo Bancshares
TCBK
$1.85B
| $366K | 0.01% |
15,800
-3,900
| -20% | -$92.5K |
|
686
FedEx
FDX
$74.5B
| $357K | 0.01% |
2,360
-37,103
| -94% | -$5.18M |
|
687
Cracker Barrel
CBRL
$1.2B
| $353K | 0.01% |
3,550
-48,821
| -93% | -$4.78M |
|
|
PXD
688
DELISTED
Pioneer Natural Resource Co.
PXD
| $349K | 0.01% |
1,520
-27,890
| -95% | -$5.76M |
|
|
WSR
689
DELISTED
Whitestone REIT
WSR
| $347K | 0.01% |
23,294
-13,200
| -36% | -$188K |
|
|
SRDX
690
DELISTED
Surmodics
SRDX
| $346K | 0.01% |
16,150
-16,300
| -50% | -$349K |
|
|
ARRY
691
DELISTED
Array Biopharma Inc
ARRY
| $345K | 0.01% |
+75,700
| New | +$313K |
|
692
Vicor
VICR
$9.62B
| $344K | 0.01% |
41,080
+6,881
| +20% | +$55.8K |
|
|
FALC
693
DELISTED
FalconStor Software Inc
FALC
| $341K | 0.01% |
200,775
+2,800
| +1% | +$4.42K |
|
|
LPDX
694
DELISTED
LIPOSCIENCE INC COM
LPDX
| $337K | 0.01% |
98,679
+34,686
| +54% | +$111K |
|
|
SAFM
695
DELISTED
Sanderson Farms Inc
SAFM
| $336K | 0.01% |
3,460
-131,973
| -97% | -$11.4M |
|
696
Stereotaxis
STXS
$129M
| $329K | 0.01% |
+115,786
| New | +$345K |
|
697
Camden Property Trust
CPT
$11.3B
| $327K | 0.01% |
+4,600
| New | +$320K |
|
|
CSS
698
DELISTED
CSS Industries, Inc.
CSS
| $324K | 0.01% |
+12,294
| New | +$310K |
|
|
XRM
699
DELISTED
Xerium Technologies Inc (new)
XRM
| $320K | 0.01% |
22,917
-16,563
| -42% | -$228K |
|
700
NACCO Industries
NC
$353M
| $319K | 0.01% |
27,619
+2,407
| +10% | +$29.1K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2014 Portfolio in Review
As of Q2 2014, Jacobs Levy Equity Management held 1,047 positions worth $6.04B, up 1.2% from $5.97B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q2 2014 filing shows 173 new, 233 increased, 390 reduced and 225 closed positions. Its largest new stake was Merck: 856,750 shares worth $47.3M. The largest sale was DIRECTV COM STK (DE), an estimated $51.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.
- Jacobs Levy Equity Management's largest Q2 2014 buy was Merck: 856,750 shares worth $47.3M.
- Jacobs Levy Equity Management added most to Pfizer in Q2 2014, an estimated $50M increase.
- Jacobs Levy Equity Management's biggest Q2 2014 reduction was Comcast, cutting an estimated $48.7M.
- Jacobs Levy Equity Management fully exited DIRECTV COM STK (DE) in Q2 2014, selling an estimated $51.6M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $6.04B portfolio in Q2 2014.
- Jacobs Levy Equity Management opened 173 new positions and closed 225 in Q2 2014.
- Jacobs Levy Equity Management's portfolio value rose 1.2% quarter-over-quarter to $6.04B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2014, filed 14 Aug 2014.